微粒化非诺贝特对2型糖尿病患者血脂及血管内皮功能的影响
非诺贝特,糖尿病,血管内皮,非诺贝特,1资料与方法,2结果,参考文献
【摘要】 目的 探讨非诺贝特对2型糖尿病患者血脂和血管内皮功能的作用。方法 60例2型糖尿病患者随机分为两组,分别给予非诺贝特或安慰剂治疗12周,利用高分辨率超声测定血流或硝酸甘油介导的肱动脉舒张,并观察血脂变化。结果 两组治疗前血糖、血脂水平相似。12周后,非诺贝特组甘油三酯显著下降,高密度脂蛋白-胆固醇升高,血流介导的血管舒张(7.66±1.35)%显著增加,较同组治疗前(4.21±1.62)%和安慰剂组治疗后(5.64±1.58)%均显著增加。12周后,两组硝酸甘油介导的舒张反应相似,较治疗前轻度改善。结论 非诺贝特可调节2型糖尿病患者血脂水平,改善内皮依赖性的血管舒张功能。关键词 糖尿病 血管内皮 非诺贝特
Effects of micronied fenofibrate on blood lipid and endothelial function in patients with type2diabetes mellitus
Peng Gang,Xi Ruixia,Shu Maoqin,et al.
Department of Cardiology,the People’s Hospital of Qijiang county401420.
【Abstract】 Objective To explore the effects of fenofibrate on the blood lipid and the endothelial function in patients with2type diabetes.Methods 60patients with type2diabetes mellitus were randomized into fenofibrate200mg daily(n=20)or placebo(n=20)for12weeks.The endothelium-dependent flow-mediated vasodilatation(FMD)and nitroglycerin-mediated vasodilatation(NTG-MD)was measured by brachial ultrasound exam.The Serum lipid profile was determined enzymatically at baseline and after12weeks treatment with or without fenofibrate.Results Total and LDL cholesterol and HDL-C and TG levels were similar before randomization in both groups.After12weeks treatment with fenofibrate ......
您现在查看是摘要页,全文长 10099 字符。